No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay

Shingo Maeda, Yoshiro Saikawa, Tetsuro Kubota, Masahiko Aoki, Yoshihide Otani, Toshiharu Furukawa, Masahiko Watanabe, Koichiro Kumai, Masaki Kitajima

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

To evaluate the clinical usefulness of taxanes as antitumor agents, we compared the antitumor spectrum of taxanes with those of conventional antitumor agents against 88 fresh gastric cancer specimens by MTT assay. At cut-off concentrations of 100 μ/ml for taxotere (Docetaxel, DOC) and 300/μml for taxol (Paclitaxel, PAC), both agents showed a higher efficacy rate than mitomycin C (MMC), cisplatin (CDDP) and 5-fluorouracil (5-FU) against the gastric cancer specimens. The patterns of antitumor activity of DOC and PAC were independent from those of the conventional agents, while the patterns of antitumor activity of the taxanes significantly correlated with each other. Conventional agent antitumor activity patterns tended to correlate with the patterns of other conventional agents. In conclusion, taxanes may be useful for clinical application against gastric cancer due to their different antitumor spectrum as compared to conventional agents.

Original languageEnglish
Pages (from-to)3147-3150
Number of pages4
JournalAnticancer research
Volume23
Issue number4
Publication statusPublished - 2003 Jul 1

Keywords

  • Gastric cancer
  • MTT assay
  • Taxol
  • Taxotere

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay'. Together they form a unique fingerprint.

  • Cite this

    Maeda, S., Saikawa, Y., Kubota, T., Aoki, M., Otani, Y., Furukawa, T., Watanabe, M., Kumai, K., & Kitajima, M. (2003). No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay. Anticancer research, 23(4), 3147-3150.